ESAB Corporation (ESAB) — Fundamental Analysis

ESAB Corporation is a steady, cash-generative industrial business that has grown revenue from roughly $1.95 billion in 2020 to $2.84 billion in 2025, while meaningfully expanding its gross and operating margins over that same stretch. The company runs a capital-light model — spending less than 2 cents of every revenue dollar on physical plant and equipment — and has progressively paid down debt, cutting its debt-to-equity ratio nearly in half since 2022. Profitability is solid, with EBITDA approaching half a billion dollars annually. The most recent quarter (ending July 3, 2026) shows some margin compression and a notable uptick in leverage, which is worth watching, but the longer-term picture remains one of a well-run, modestly growing industrial compounder with improving fundamentals and disciplined capital allocation.

Snapshot & Big Picture

ESAB was spun out of Colfax Corporation in April 2022 and is a global leader in welding, cutting, and gas control equipment and consumables. Its product mix — heavily weighted toward consumables — gives it recurring, relatively defensive revenue. The company serves a broad range of end markets including general fabrication, infrastructure, energy, and shipbuilding. Over the five full fiscal years captured in its SEC filings, ESAB has compounded revenue at roughly 7.8% annually (from 2020 to 2025), expanded gross margins from ~35% to nearly 37%, and converted an improving share of that revenue into operating income.

Latest Quarter Snapshot

The most recent data comes from ESAB's 10-Q for the quarter ending July 3, 2026, filed August 6, 2026 — making it more current than any of the annual figures above. Revenue for the quarter was $807.6 million, tracking at an annualized pace broadly in line with recent annual run rates. However, margins compressed noticeably: gross margin came in at 38.0% (roughly in line with recent annual levels), but the operating margin fell to 9.7% and the net margin dropped to just 4.0% — well below the full-year 2024 and 2025 figures. This suggests elevated below-the-line costs or one-time items in the period. The current ratio improved to 1.96, indicating healthy near-term liquidity, but the debt-to-equity ratio jumped to 0.94 — the highest level since the company's earliest post-spin filings — suggesting ESAB may have taken on incremental debt, potentially for an acquisition or other capital allocation activity.

Profitability

ESAB's profitability trend across the annual data is encouraging. Gross margins have expanded roughly 260 basis points from 2020 (35.0%) to 2025 (36.9%), with 2024 representing the high-water mark at 37.9%. Operating margins followed a similar arc — rising from 10.4% in 2020 to a peak of 16.3% in 2024, before easing back to 14.5% in 2025. Net margins have been somewhat variable (ranging from 7.4% to 9.7%), reflecting the influence of interest expense, taxes, and below-the-line items in any given year. EBITDA grew from $278.8M in 2020 to $514.2M in 2024, though it dipped modestly to $496.3M in 2025. Overall, the multi-year direction is one of margin improvement and earnings quality growth, even if the most recent annual and quarterly figures suggest some near-term pressure.

Financial Health

ESAB's balance sheet has strengthened materially since 2022. The debt-to-equity ratio peaked at 0.90 in 2022 (the company's first full year post-spin with reportable leverage) and has since declined to 0.57 by fiscal year-end 2025 — reflecting ongoing debt repayment and/or equity accumulation. The current ratio has also improved, rising from 1.61 in 2022 to 1.90 in 2025 and 1.96 in the most recent quarter, pointing to solid short-term liquidity. The one notable flag is the Q2 2026 debt-to-equity spike to 0.94, which reverses some of that progress and warrants monitoring in future filings.

Capital Expenditures: ESAB is a notably capital-light business. Annual CapEx has ranged from $35.6M (2021) to $51.8M (2024), never exceeding 2.1% of revenue in any year covered by the data. The most recent quarter's CapEx of $13.7M (1.70% of revenue) is consistent with that pattern. Importantly, this ratio has been gradually trending slightly downward — from 2.06% in 2020 to 1.66% in 2025 — implying that ESAB is becoming incrementally more efficient in its reinvestment requirements rather than needing to spend more to sustain growth. For an industrial company, this is a positive signal: it means more free cash flow is available for debt reduction, dividends, buybacks, or M&A, and the business is not becoming more capital-intensive as it scales.

Growth

The table below shows ESAB's revenue CAGR across the available measurement windows. A 10-year CAGR is not available because ESAB only became an independent public company in 2022 and does not have 10 years of standalone SEC filing history.

The 5-year CAGR of 7.8% looks healthy for an industrial company, but much of that reflects the step-change in revenue between 2020 and 2022 — a period that included post-COVID recovery and the impact of ESAB's separation from Colfax. The more recent 3-year CAGR of just 3.1% (2022–2025) tells a more measured story: organic growth has moderated as the easy recovery tailwinds faded, and revenue was essentially flat between 2023 and 2024. Investors should monitor whether the company can reaccelerate growth through geographic expansion, new product categories, or bolt-on M&A.

Source Filings

• 10-Q filed August 6, 2026 — Period ending July 3, 2026
• 10-Q filed May 7, 2026 — Period ending April 3, 2026